B.R. Reeves

2.9k total citations
54 papers, 2.2k citations indexed

About

B.R. Reeves is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, B.R. Reeves has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 17 papers in Molecular Biology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in B.R. Reeves's work include Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Acute Lymphoblastic Leukemia research (11 papers). B.R. Reeves is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Acute Lymphoblastic Leukemia research (11 papers). B.R. Reeves collaborates with scholars based in United Kingdom, United States and India. B.R. Reeves's co-authors include Judith M. Chessells, SylviaD. Lawler, Sylvia D. Lawler, G. John Swansbury, S. D. Lawler, P. L. Lantos, Michael R. Stratton, John L. Darling, Owen Smith and Peter J. Milla and has published in prestigious journals such as Cell, The Lancet and Blood.

In The Last Decade

B.R. Reeves

54 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.R. Reeves United Kingdom 30 829 736 467 427 423 54 2.2k
Wolfram Ebell Germany 28 938 1.1× 823 1.1× 288 0.6× 605 1.4× 839 2.0× 85 2.9k
W. Havers Germany 26 602 0.7× 577 0.8× 210 0.4× 432 1.0× 600 1.4× 76 2.1k
Robert R. Chilcote United States 21 522 0.6× 440 0.6× 173 0.4× 514 1.2× 565 1.3× 47 2.4k
F. Lampert Germany 28 1.3k 1.6× 1.2k 1.6× 276 0.6× 407 1.0× 1.4k 3.4× 133 3.3k
Rinat Bernstein‐Molho Israel 25 577 0.7× 594 0.8× 626 1.3× 218 0.5× 271 0.6× 116 1.9k
MP Link United States 32 1.2k 1.5× 841 1.1× 213 0.5× 543 1.3× 1.2k 2.8× 67 2.8k
Carrie Fidler United Kingdom 28 1.1k 1.3× 972 1.3× 383 0.8× 268 0.6× 106 0.3× 61 2.8k
Patricia A. Dinndorf United States 18 581 0.7× 373 0.5× 318 0.7× 253 0.6× 408 1.0× 36 1.8k
B. Kornhuber Germany 24 1.4k 1.6× 595 0.8× 123 0.3× 402 0.9× 878 2.1× 79 2.8k
Kristin Baird United States 27 823 1.0× 652 0.9× 301 0.6× 755 1.8× 292 0.7× 71 3.0k

Countries citing papers authored by B.R. Reeves

Since Specialization
Citations

This map shows the geographic impact of B.R. Reeves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.R. Reeves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.R. Reeves more than expected).

Fields of papers citing papers by B.R. Reeves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.R. Reeves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.R. Reeves. The network helps show where B.R. Reeves may publish in the future.

Co-authorship network of co-authors of B.R. Reeves

This figure shows the co-authorship network connecting the top 25 collaborators of B.R. Reeves. A scholar is included among the top collaborators of B.R. Reeves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.R. Reeves. B.R. Reeves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uemura, Tadahiro, Thomas Riley, Akhtar Khan, et al.. (2010). Immune functional assay for immunosuppressive management in post-transplant malignancy. Clinical Transplantation. 25(1). E32–E37. 15 indexed citations
2.
Kempski, Helena, et al.. (1998). Cryptic deletions and inversions of chromosome 21 in a phenotypically normal infant with transient abnormal myelopoiesis: a molecular cytogenetic study. British Journal of Haematology. 103(2). 473–479. 21 indexed citations
3.
Chessells, Judith M., G. John Swansbury, B.R. Reeves, C. C. Bailey, & S Richards. (1997). Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. British Journal of Haematology. 99(1). 93–100. 112 indexed citations
4.
Smith, Owen, Ian Hann, Judith M. Chessells, B.R. Reeves, & Peter J. Milla. (1996). Haematological abnormalities in Shwachman‐Diamond syndrome. British Journal of Haematology. 94(2). 279–284. 142 indexed citations
5.
Smith, Owen, B.R. Reeves, Helena Kempski, & J. P. M. Evans. (1995). Kostmann's disease, recombinant HuG‐CSF, monosomy 7 and MDS/AML. British Journal of Haematology. 91(1). 150–153. 15 indexed citations
6.
Renwick, P., B.R. Reeves, Paola Dal Cin, et al.. (1995). Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma. Cytogenetic and Genome Research. 70(1-2). 58–63. 53 indexed citations
7.
Katz, F, B.R. Reeves, Shirley Alexander, Robert E. Kearney, & Judith M. Chessells. (1993). Leukaemia arising in donor cells following allogeneic bone marrow transplantation for β thalassaemia demonstrated by immunological, DNA and molecular cytogenetic analysis. British Journal of Haematology. 85(2). 326–331. 29 indexed citations
8.
Katz, F, David Webb, Barbara Gibbons, et al.. (1992). Possible evidence for genomic imprinting in childhood acute myeloblastic leukaemia associated with monosomy for chromosome 7. British Journal of Haematology. 80(3). 332–336. 32 indexed citations
9.
Reeves, B.R., et al.. (1992). Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization. Human Molecular Genetics. 1(8). 633–637. 33 indexed citations
10.
Cooper, Christopher S., et al.. (1991). A case of cerebellar medulloblastoma with a single chromosome abnormality. Cancer Genetics and Cytogenetics. 53(1). 101–103. 14 indexed citations
11.
Stratton, Michael R., John L. Darling, P. L. Lantos, Christopher S. Cooper, & B.R. Reeves. (1989). Cytogenetic abnormalities in human ependymomas. International Journal of Cancer. 44(4). 579–581. 52 indexed citations
12.
Stratton, Michael R., John L. Darling, Gerlinde Pilkington, et al.. (1989). Characterization of the human cell line TE671. Carcinogenesis. 10(5). 899–905. 144 indexed citations
13.
Arthur, D, Roland Berger, Harvey M. Golomb, et al.. (1989). The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genetics and Cytogenetics. 40(2). 203–216. 147 indexed citations
14.
Pierre, Robert V., Daniel Catovsky, G J Mufti, et al.. (1989). Clinical-cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genetics and Cytogenetics. 40(2). 149–161. 102 indexed citations
15.
Secker‐Walker, Lorna M., Giuliana Alimena, C. D. Bloomfield, et al.. (1989). Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapse. Cancer Genetics and Cytogenetics. 40(2). 163–169. 19 indexed citations
16.
Renan, M.J. & B.R. Reeves. (1987). Chromosomal localization of human endogenous retroviral element ERV1 to 18q22→q23 by in situ hybridization. Cytogenetic and Genome Research. 44(2-3). 167–170. 10 indexed citations
17.
Reeves, B.R., et al.. (1974). Preferential location of chlorambucil-induced breakage in the chromosomes of normal human lymphocytes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 26(3). 205–208. 36 indexed citations
18.
Reeves, B.R.. (1973). Cytogenetics of Malignant Lymphomas. Human Genetics. 20(3). 231–250. 92 indexed citations
19.
Lawler, S. D., et al.. (1967). Chromosomes in Hodgkin's Disease. BMJ. 3(5569). 865.2–865. 1 indexed citations
20.
Lawler, S. D., et al.. (1967). Lymphocyte transformation and chromosome studies in Hodgkin's disease.. BMJ. 3(5567). 704–708. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfram Ebell Breakdown of academic impact, for papers by W. Havers Breakdown of academic impact, for papers by Robert R. Chilcote Breakdown of academic impact, for papers by F. Lampert Breakdown of academic impact, for papers by Rinat Bernstein‐Molho Breakdown of academic impact, for papers by MP Link Breakdown of academic impact, for papers by Carrie Fidler Breakdown of academic impact, for papers by Patricia A. Dinndorf Breakdown of academic impact, for papers by B. Kornhuber Breakdown of academic impact, for papers by Kristin Baird
Rankless by CCL
2026